Cavo M; Tacchetti P; Patriarca F; Petrucci MT; Pantani L; Galli M; Di Raimondo F; Crippa C; Zamagni E; Palumbo A; Offidani M; Corradini P; Narni F; Spadano A; Pescosta N; Deliliers GL; Ledda A; Cellini C; Caravita T; Tosi P; Baccarani M, Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study., «THE LANCET», 2010, 376, pp. 2075 - 2085 [articolo]
Terragna C.; Remondini D.; Martinelli G.; Tosi P.; Zamagni E.; Tacchetti P.; Perrone G.; Brioli A.; Ceccolini M.; Testoni N.; Marzocchi G.; Castellani G.; Durante S.; Di Raimondo F.; Patriarca F.; Catalano L.; Masini L.; Ledda A.; Angelucci E.; Galieni P.; Gozzetti A.; Baccarani M.; Cavo M., CLINICAL OUTCOMES PREDICTION FOR NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH THALIDOMIDE-DEXAMETHASONE AND AUTOLOGOUS STEM CELL TRANSPLANTATION BY 8-GENE SIGNATURE OF CD138+ PLASMA CELLS, in: Haematologica, «HAEMATOLOGICA», 2010, 95[suppl.2], pp. 214 - 214 (atti di: 15th Congress of the European Hematology Association, June 10-13, 2010, Barcelona, Spain, June 10 - 13, 2010;) [atti di convegno-abstract]
Engelhardt M; Kleber M; Udi J; Wäsch R; Spencer A; Patriarca F; Knop S; Bruno B; Gramatzki M; Morabito F; Kropff M; Neri A; Sezer O; Hajek R; Bunjes D; Boccadoro M; Straka C; Cavo M; Polliack A; Einsele H; Palumbo A., Consensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approaches., «LEUKEMIA & LYMPHOMA», 2010, 51, pp. 1424 - 1443 [articolo]
Ludwig H; Beksac M; Bladé J; Boccadoro M; Cavenagh J; Cavo M; Dimopoulos M; Drach J; Einsele H; Facon T; Goldschmidt H; Harousseau JL; Hess U; Ketterer N; Kropff M; Mendeleeva L; Morgan G; Palumbo A; Plesner T; San Miguel J; Shpilberg O; Sondergeld P; Sonneveld P; Zweegman S., Current multiple myeloma treatment strategies with novel agents: a European perspective, «THE ONCOLOGIST», 2010, 15, pp. 6 - 25 [articolo]
Bringhen S; Larocca A; Rossi D; Cavalli M; Genuardi M; Ria R; Gentili S;
Patriarca F; Nozzoli C; Levi A; Guglielmelli T; Benevolo G; Callea V; Rizzo V; Cangialosi C; Musto P; De Rosa L; Liberati AM; Grasso M; Falcone AP; Evangelista A; Cavo M; Gaidano G; Boccadoro M; Palumbo A., Efficacy and safety of once-weekly bortezomib in multiple myeloma patients., «BLOOD», 2010, 116, pp. 4745 - 4753 [articolo]
Engelhardt M; Udi J; Kleber M; Spencer A; Rocci A; Knop S; Bruno B; Bringhen S; Pérez-Simón JA; Zweegman S; Driessen C; Patriarca F; Gramatzki M; Terpos E; Sezer O; Kropff M; Straka C; Johnsen HE; Waage A; Boegsted M; Lokhorst H; Hájek R; Morgan G; Boccadoro M; Ludwig H; Cavo M; Polliack A; Sonneveld P; Einsele H; Palumbo A., European Myeloma Network: the 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myeloma., «LEUKEMIA & LYMPHOMA», 2010, 51, pp. 2006 - 2011 [articolo]
Mehta J; Cavo M; Singhal S., How I treat elderly patients with myeloma., «BLOOD», 2010, 116, pp. 2215 - 2223 [articolo]
Kyle RA; Durie BG; Rajkumar SV; Landgren O; Blade J; Merlini G; Kröger N; Einsele H; Vesole DH; Dimopoulos M; San Miguel J; Avet-Loiseau H; Hajek R; Chen WM; Anderson KC; Ludwig H; Sonneveld P; Pavlovsky S; Palumbo A; Richardson PG; Barlogie B; Greipp P; Vescio R; Turesson I; Westin J; Boccadoro M; Cavo M, Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management., «LEUKEMIA», 2010, 24, pp. 1121 - 1127 [articolo]
Dimopoulos MA; Terpos E; Chanan-Khan A; Leung N; Ludwig H; Jagannath S; Niesvizky R; Giralt S; Fermand JP; Bladé J; Comenzo RL; Sezer O; Palumbo A; Harousseau JL; Richardson PG; Barlogie B; Anderson KC; Sonneveld P; Tosi P; Cavo M; Rajkumar SV; Durie BG; San Miguel J, Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group., «JOURNAL OF CLINICAL ONCOLOGY», 2010, 28, pp. 4976 - 4984 [articolo]
Morabito F; Gentile M; Ciolli S; Petrucci MT; Galimberti S; Mele G; Casulli AF; Mannina D; Piro E; Pinotti G; Palmieri S; Catalano L; Callea V; Offidani M; Musto P; Bringhen S; Baldini L; Tosi P; Di Raimondo F; Boccadoro M; Palumbo A; Cavo M., Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMA., «EUROPEAN JOURNAL OF HAEMATOLOGY», 2010, 84 (3), pp. 223 - 228 [articolo]
Harousseau JL; Palumbo A; Richardson PG; Schlag R; Dimopoulos MA; Shpilberg O; Kropff M; Kentos A; Cavo M; Golenkov A; Komarnicki M; Mateos MV; Esseltine DL; Cakana A; Liu K; Deraedt W; van de Velde H; San Miguel JF., Superior outcomes associated with complete response in newly diagnosed multiple myeloma patients treated with nonintensive therapy: analysis of the phase 3 VISTA study of bortezomib plus melphalan-prednisone versus melphalan-prednisone., «BLOOD», 2010, 116, pp. 3743 - 3750 [articolo]
Ludwig H; Bolejack V; Crowley J; Bladé J; Miguel JS; Kyle RA; Rajkumar SV; Shimizu K; Turesson I; Westin J; Sonneveld P; Cavo M; Boccadoro M; Palumbo A; Tosi P; Harousseau JL; Attal M; Barlogie B; Stewart AK; Durie B., Survival and years of life lost in different age cohorts of patients with multiple myeloma., «JOURNAL OF CLINICAL ONCOLOGY», 2010, 28, pp. 1599 - 1605 [articolo]
Tosi P; Zamagni E; Tacchetti P; Ceccolini M; Perrone G; Brioli A; Pallotti MC; Pantani L; Petrucci A; Baccarani M; Cavo M., Thalidomide-dexamethasone as induction therapy before autologous stem cell transplantation in patients with newly diagnosed multiple myeloma and renal insufficiency., «BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION», 2010, 16, pp. 1115 - 1121 [articolo]
Cini M; Zamagni E; Valdré L; Palareti G; Patriarca F; Tacchetti P; Legnani C; Catalano L; Masini L; Tosi P; Gozzetti A; Cavo M, Thalidomide-dexamethasone as up-front therapy for patients with newly diagnosed multiple myeloma: thrombophilic alterations, thrombotic complications, and thromboprophylaxis with low-dose warfarin., «EUROPEAN JOURNAL OF HAEMATOLOGY», 2010, 84, pp. 484 - 492 [articolo]
Perrone G; Hideshima T; Ikeda H; Okawa Y; Calabrese E; Gorgun G; Santo L; Cirstea D; Raje N; Chauhan D; Baccarani M; Cavo M; Anderson KC., Ascorbic acid inhibits antitumor activity of bortezomib in vivo, «LEUKEMIA», 2009, 23(9), pp. 1679 - 1686 [articolo]
